LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
28.65
+0.22 (0.77%)
Nov 5, 2024, 4:00 PM EST - Market closed
LENZ Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | - |
| Debt / FCF Ratio | -0.02 | -0.01 | -0.06 | - |
| Asset Turnover | - | - | 0.46 | - |
| Quick Ratio | 22.85 | 3.55 | 4.68 | 14.61 |
| Current Ratio | 23.23 | 3.63 | 4.91 | 14.62 |
| Return on Equity (ROE) | - | -157.61% | -39.80% | - |
| Return on Assets (ROA) | - | -77.17% | -20.07% | - |
| Return on Capital (ROIC) | - | -101.31% | -24.01% | - |
| Buyback Yield / Dilution | -72.32% | -2.47% | -1.05% | - |
| Total Shareholder Return | -72.32% | -2.47% | -1.05% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.